Photo from Teresa Macarulla from vhio.net
Jun 27, 2024, 14:31
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024, as well as online, through a dedicated virtual platform. The congress will be the place to present impactful new data in GI oncology.
Teresa Macarulla, GI Medical Oncologist at the Vall d’Hebron Institute of Oncology, shared a few highlights from the conference.
Thomas Seufferlein reviews the role of personalised medicine in the PDAC
Educational session in ESMOGI24.
- NGS testing make sense, but is not the only means
- targeting KRAS may be a game changer
- importance of molecular tumor board
Florencia Mcallister in the PDAC educational session in ESMOGI24
Excellent presentation:
- PDAC universal genetic testing is the standard
- Importance of multi- institutional research effort for early detection projects in PDAC
Management of precancerous lesions in PDAC.
Maria Reig nicely reviewed treatment of localised tumours in the HCC educational session.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 09:04
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12